Susquehanna International Group, LLP Calliditas Therapeutics Ab Transaction History

Susquehanna International Group, LLP

  • $641 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024
SELL
$17.65 - $41.41 $86,132 - $202,080
-4,880 Reduced 47.48%
5,397 $210,000
Q1 2024

May 07, 2024
BUY
$20.04 - $25.66 $17,334 - $22,195
865 Added 9.19%
10,277 $215,000
Q4 2023

Feb 14, 2024
BUY
$15.79 - $28.99 $148,615 - $272,853
9,412 New
9,412 $242,000

Others Institutions Holding CALT

# of Institutions
1
Shares Held
18
Call Options Held
0
Put Options Held
0
View Full List

About Calliditas Therapeutics AB

CALT Quotes by TradingView
  • Ticker CALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,624,800
  • Market Cap $1.06B
  • Description
  • Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...
More about CALT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email